Skip to main content
OpenTrials

Clinical trial condition

Metastatic Esophageal Squamous Cell Carcinoma

Explore clinical trials studying Metastatic Esophageal Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.

11 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Esophageal Squamous Cell Carcinoma trial results

Terminated

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014).

NCT04949256

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +14 more
Locations
  • City of Hope ( Site 0102) Duarte, California, United States
  • MedStar Washington Hospital Center ( Site 0186) Washington D.C., District of Columbia, United States
  • James Graham Brown Cancer Center ( Site 0117) Louisville, Kentucky, United States
  • Norton Cancer Institute ( Site 0116) Louisville, Kentucky, United States
View all 198 locations
View Trial Details

Related conditions